231 related articles for article (PubMed ID: 34758303)
21. NMDA Receptors Containing GluN2B/2C/2D Subunits Mediate an Increase in Glutamate Release at Hippocampal CA3-CA1 Synapses.
Prius-Mengual J; Pérez-Rodríguez M; Andrade-Talavera Y; Rodríguez-Moreno A
Mol Neurobiol; 2019 Mar; 56(3):1694-1706. PubMed ID: 29916144
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of Nwd1 activity attenuates neuronal hyperexcitability and GluN2B phosphorylation in the hippocampus.
Yang Q; Huang Z; Luo Y; Zheng F; Hu Y; Liu H; Zhu S; He M; Xu D; Li Y; Yang M; Yang Y; Wei X; Gao X; Wang W; Ma J; Ma Y; Wang X; Wang Q
EBioMedicine; 2019 Sep; 47():470-483. PubMed ID: 31474551
[TBL] [Abstract][Full Text] [Related]
23. Induction of Inhibitory Synaptic Plasticity Enhances Tonic Current by Increasing the Content of α5-Subunit Containing GABA
Wyroślak M; Lebida K; Mozrzymas JW
Neuroscience; 2021 Jul; 467():39-46. PubMed ID: 34033868
[TBL] [Abstract][Full Text] [Related]
24. Subunit-selective N-Methyl-d-aspartate (NMDA) Receptor Signaling through Brefeldin A-resistant Arf Guanine Nucleotide Exchange Factors BRAG1 and BRAG2 during Synapse Maturation.
Elagabani MN; Briševac D; Kintscher M; Pohle J; Köhr G; Schmitz D; Kornau HC
J Biol Chem; 2016 Apr; 291(17):9105-18. PubMed ID: 26884337
[TBL] [Abstract][Full Text] [Related]
25. Role of nonsynaptic GluN2B-containing NMDA receptors in excitotoxicity: evidence that fluoxetine selectively inhibits these receptors and may have neuroprotective effects.
Vizi ES; Kisfali M; Lőrincz T
Brain Res Bull; 2013 Apr; 93():32-8. PubMed ID: 23089362
[TBL] [Abstract][Full Text] [Related]
26. The Developmental Shift of NMDA Receptor Composition Proceeds Independently of GluN2 Subunit-Specific GluN2 C-Terminal Sequences.
McKay S; Ryan TJ; McQueen J; Indersmitten T; Marwick KFM; Hasel P; Kopanitsa MV; Baxter PS; Martel MA; Kind PC; Wyllie DJA; O'Dell TJ; Grant SGN; Hardingham GE; Komiyama NH
Cell Rep; 2018 Oct; 25(4):841-851.e4. PubMed ID: 30355491
[TBL] [Abstract][Full Text] [Related]
27. 14-3-3 proteins promote synaptic localization of N-methyl d-aspartate receptors (NMDARs) in mouse hippocampal and cortical neurons.
Lee GS; Zhang J; Wu Y; Zhou Y
PLoS One; 2021; 16(12):e0261791. PubMed ID: 34962957
[TBL] [Abstract][Full Text] [Related]
28. Developmental Changes of Synaptic and Extrasynaptic NMDA Receptor Expression in Rat Cerebellar Neurons In Vitro.
Sibarov DA; Stepanenko YD; Silantiev IV; Abushik PA; Karelina TV; Antonov SM
J Mol Neurosci; 2018 Feb; 64(2):300-311. PubMed ID: 29285738
[TBL] [Abstract][Full Text] [Related]
29. Activity- and sleep-dependent regulation of tonic inhibition by Shisa7.
Wu K; Han W; Tian Q; Li Y; Lu W
Cell Rep; 2021 Mar; 34(12):108899. PubMed ID: 33761345
[TBL] [Abstract][Full Text] [Related]
30. A Rare Variant Identified Within the GluN2B C-Terminus in a Patient with Autism Affects NMDA Receptor Surface Expression and Spine Density.
Liu S; Zhou L; Yuan H; Vieira M; Sanz-Clemente A; Badger JD; Lu W; Traynelis SF; Roche KW
J Neurosci; 2017 Apr; 37(15):4093-4102. PubMed ID: 28283559
[TBL] [Abstract][Full Text] [Related]
31. NMDA receptor GluN2B (GluR epsilon 2/NR2B) subunit is crucial for channel function, postsynaptic macromolecular organization, and actin cytoskeleton at hippocampal CA3 synapses.
Akashi K; Kakizaki T; Kamiya H; Fukaya M; Yamasaki M; Abe M; Natsume R; Watanabe M; Sakimura K
J Neurosci; 2009 Sep; 29(35):10869-82. PubMed ID: 19726645
[TBL] [Abstract][Full Text] [Related]
32. Afferent Input Selects NMDA Receptor Subtype to Determine the Persistency of Hippocampal LTP in Freely Behaving Mice.
Ballesteros JJ; Buschler A; Köhr G; Manahan-Vaughan D
Front Synaptic Neurosci; 2016; 8():33. PubMed ID: 27818632
[TBL] [Abstract][Full Text] [Related]
33. Identity of the NMDA receptor coagonist is synapse specific and developmentally regulated in the hippocampus.
Le Bail M; Martineau M; Sacchi S; Yatsenko N; Radzishevsky I; Conrod S; Ait Ouares K; Wolosker H; Pollegioni L; Billard JM; Mothet JP
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):E204-13. PubMed ID: 25550512
[TBL] [Abstract][Full Text] [Related]
34. Enhanced Dendritic Inhibition and Impaired NMDAR Activation in a Mouse Model of Down Syndrome.
Schulz JM; Knoflach F; Hernandez MC; Bischofberger J
J Neurosci; 2019 Jun; 39(26):5210-5221. PubMed ID: 31000585
[TBL] [Abstract][Full Text] [Related]
35. Preferential Inhibition of Tonically over Phasically Activated NMDA Receptors by Pregnane Derivatives.
Vyklicky V; Smejkalova T; Krausova B; Balik A; Korinek M; Borovska J; Horak M; Chvojkova M; Kleteckova L; Vales K; Cerny J; Nekardova M; Chodounska H; Kudova E; Vyklicky L
J Neurosci; 2016 Feb; 36(7):2161-75. PubMed ID: 26888927
[TBL] [Abstract][Full Text] [Related]
36. NMDA receptors in hippocampal GABAergic synapses and their role in nitric oxide signaling.
Szabadits E; Cserép C; Szonyi A; Fukazawa Y; Shigemoto R; Watanabe M; Itohara S; Freund TF; Nyiri G
J Neurosci; 2011 Apr; 31(16):5893-904. PubMed ID: 21508214
[TBL] [Abstract][Full Text] [Related]
37. Tonically active NMDA receptors--a signalling mechanism critical for interneuronal excitability in the CA1 stratum radiatum.
Riebe I; Seth H; Culley G; Dósa Z; Radi S; Strand K; Fröjd V; Hanse E
Eur J Neurosci; 2016 Jan; 43(2):169-78. PubMed ID: 26547631
[TBL] [Abstract][Full Text] [Related]
38. The role of GluN2A and GluN2B NMDA receptor subunits in AgRP and POMC neurons on body weight and glucose homeostasis.
Üner A; Gonçalves GH; Li W; Porceban M; Caron N; Schönke M; Delpire E; Sakimura K; Bjørbæk C
Mol Metab; 2015 Oct; 4(10):678-91. PubMed ID: 26500840
[TBL] [Abstract][Full Text] [Related]
39. Effects of GluN2A and GluN2B gain-of-function epilepsy mutations on synaptic currents mediated by diheteromeric and triheteromeric NMDA receptors.
Chen X; Keramidas A; Harvey RJ; Lynch JW
Neurobiol Dis; 2020 Jul; 140():104850. PubMed ID: 32247039
[TBL] [Abstract][Full Text] [Related]
40. Enhancing GluN2A-type NMDA receptors impairs long-term synaptic plasticity and learning and memory.
Li QQ; Chen J; Hu P; Jia M; Sun JH; Feng HY; Qiao FC; Zang YY; Shi YY; Chen G; Sheng N; Xu Y; Yang JJ; Xu Z; Shi YS
Mol Psychiatry; 2022 Aug; 27(8):3468-3478. PubMed ID: 35484243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
